Pain researcher in Italy up to seven retractions

Marco Monticone

A physiatrist in Italy has lost four publications this year after two groups of researchers raised concerns about his research.

The physician, Marco Monticone, a professor at the University of Cagliari, had three papers pulled in 2022, as we reported at the time. Those retractions followed a critique by Cochrane researchers who analyzed data in 10 randomized controlled trials (RCTs) headed by Monticone.

Neil O’Connell, of Brunel University of London, lead author of the critique, told us:

Continue reading Pain researcher in Italy up to seven retractions

Who owns your thesis data? We do, says one university, prompting retraction

The University of Pavia, Yamada via Flickr

Here’s a story that’s likely to strike a sour chord with graduate students. 

A researcher in Italy has lost his 2020 paper, based on work he conducted for his doctoral thesis, after the university claimed that he didn’t have the right to publish the data. 

The paper, “Musical practice and BDNF plasma levels as a potential marker of synaptic plasticity: an instrument of rehabilitative processes,” was written by Alessandro Minutillo, now of the Department of Pathophysiology and Transplantation at the University of Milan and appeared in Neurological Sciences. His two co-authors included Massimo Carlo Mauri, a prominent psychiatrist at the Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, also in Milan. 

The study, which Minutillo conducted while a medical student at the University of Pavia, was based on data from 48 men and women, of whom 21 were musicians and 27 were non-musicians. (In case you’re wondering: “To be defined as a “musician,” the practice of any musical instrument or voice was required for at least 3 h a week. This practice had to be stable and continued for at least 5 years and the subject had to have been achieved a musical degree.”)

Per the authors: 

Continue reading Who owns your thesis data? We do, says one university, prompting retraction

Journal retracted at least 17 papers for self-citation, 14 with same first author

A medical journal in Italy has retracted at least 17 papers by researchers in that country who appear to have been caught in a citation scam. The journal says it also fired three editorial board members for “misconduct” in the matter. 

The retractions, from Acta Medica Mediterranea, occurred in 2017 and 2018, but we’re just finding out about them now; 14 involve roughly the same group of neuroscientists, while three are by different authors from some of the same institutions as the first team. 

The journal last year issued two statements on its website about the cases, which it began investigating in 2018. The first, on Feb. 1, 2019 (we think), declared: 

Continue reading Journal retracted at least 17 papers for self-citation, 14 with same first author

PLOS ONE realizes an academic editor had a conflict of interest that the publisher says it now tries harder to avoid

A group of genetics researchers in Italy has lost a 2014 paper in PLOS ONE for a range of image problems and a glaring conflict of interest. 

The article, titled “Neuronal differentiation dictates estrogen-dependent survival and ERK1/2 kinetic by means of caveolin-1,” came from a team led by Luca Colucci-D’Amato, of the Second University of Naples. 

The retraction notice in PLOS ONE lays out a raft of issues with the paper, for example:

Continue reading PLOS ONE realizes an academic editor had a conflict of interest that the publisher says it now tries harder to avoid

No ‘possible fraudulent explanation’: Frequent co-author tasked with clearing colleagues of image manipulation

University of Milano-Bicocca

A journal has allowed a group of researchers in Italy to correct a 2016 paper with questionable images after a faculty member in their institution — and a frequent co-author of the group’s — said his investigation found no reason to doubt their integrity. 

The article, “Arg tyrosine kinase modulates TGF-β1 production in human renal tubular cells under high-glucose conditions,” appeared in the Journal of Cell Science. Earlier this year, a poster on PubPeer pointed out “problematic similarities” with figures in the article. 

The similarities evidently didn’t trouble Fulvio Magni, a professor of biochemistry at Milano-Bicocca who was tasked with investigating the case. Magni, we think we should note, has also been a co-author with members of the research group (see here, here, here and here, for a few examples).

According to the correction

Continue reading No ‘possible fraudulent explanation’: Frequent co-author tasked with clearing colleagues of image manipulation

An author told a journal their institution had no one who handled allegations. Turns out that wasn’t true.

Istituto Superiore di Sanità

Should journals always take authors at their word?

Take the case of a recent expression of concern in the Journal of Cell Science following concerns about image manipulation in a 2006 paper, “Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.”

Here’s the notice:

Continue reading An author told a journal their institution had no one who handled allegations. Turns out that wasn’t true.

After university goes silent, diabetes journal retracts three papers

A group of researchers based in Italy has had three papers retracted for likely using the same images to represent different experimental conditions.

The retractions, in Diabetes, published by the American Diabetes Association (ADA), follow expressions of concern for the papers in early 2018 and the launch of an investigation by the authors’ institution into the work. The status of that investigation by Università degli Studi di Napoli Federico II, however, is unclear, as the university has stopped responding to the journal’s inquiries.

Here are the three now-retracted papers: Continue reading After university goes silent, diabetes journal retracts three papers

Engineering prof in Italy earns 26 retractions in one fell swoop

Antonio Orlandi

Antonio Orlandi, a professor of electrical engineering at the University of L’Aquila, in Italy, has had 26 papers retracted from a single journal, on a single day.

Orlandi’s retractions come with a twist: He was, until recently, the editor in chief of the journal where the articles appeared, IEEE Transactions on Electromagnetic Compatibility. Continue reading Engineering prof in Italy earns 26 retractions in one fell swoop

JAMA journal retracts paper when author can’t produce original data

In July 2017, a JAMA journal called for an investigation into a 2013 paper it had published after concluding that the article had “scientific and ethical concerns.” Now the journal, JAMA Otolaryngology − Head & Neck Surgery, is retracting the paper.

The article, “Dexamethasone for the prevention of recurrent laryngeal nerve palsy and other complications after thyroid surgery: a randomized double-blind placebo-controlled trial,” came from a group in Italy led by Mario Schietroma, of the Department of Surgery at the University of L’Aquila, in Abruzzo, Italy. Schietroma, who in December admitted to us that a retracted 2015 paper of his in the Journal of the American College of Surgeons suffered from “misinterpretation of the statistical data,” now has four retractions.

The paper has been cited a total of 18 times, according to Clarivate Analytics’ Web of Science, including twice since it was subjected to an expression of concern. One of those citations was by a Cochrane systematic review.

According to the retraction notice: Continue reading JAMA journal retracts paper when author can’t produce original data

Court orders journal to retract a paper after supplement seller sues

An Italian court has ordered a journal to retract a paper. But it hasn’t just yet.

Instead, the Journal of Ovarian Research has published an expression of concern about the 2012 paper, replete with obfuscating legal language.

Here’s the text:

Continue reading Court orders journal to retract a paper after supplement seller sues